Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.19 USD | -0.27% | -5.14% | -9.50% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.50% | 1.44B | |
+19.29% | 80.5B | |
+15.17% | 9.15B | |
-18.33% | 4.9B | |
+43.39% | 4.49B | |
+13.95% | 4.44B | |
+10.89% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Transcript : Supernus Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 27, 2024